50242-123 : Esbriet 801 mg Oral Tablet, Coated
| NDC: | 50242-123 |
| Labeler: | Genentech, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Esbriet |
| Dosage Form: | Oral Tablet, Coated |
| Application #: | NDA208780 |
| Rev. Date: |
Appearance:
| Markings: | PFD |
| Shapes: |
Oval |
| Colors: |
 Brown |
| Size (mm): | 20 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 50242-123-01: 1 BOTTLE, PLASTIC IN 1 CARTON (50242‑123‑01) > 90 TABLET, COATED IN 1 BOTTLE, PLASTIC
Active Ingredients:
- Pirfenidone
Dosage Strength:
- 801 mg
Inactive Ingredients:
- Microcrystalline Cellulose
- Silicon Dioxide
- Povidone K30
- Croscarmellose Sodium
- Magnesium Stearate
- Polyvinyl Alcohol, Unspecified
- Titanium Dioxide
- Polyethylene Glycol 3350
- Talc
- Ferric Oxide Red
- Ferrosoferric Oxide
Pharmaceutical Classes:
- Pyridone [EPC]
- Pyridones [Chemical/Ingredient]
Related Products:
Based on records with the same trade name.- 50242-121 Esbriet 267 mg Oral Capsule by Genentech, Inc.
- 50242-122 Esbriet 267 mg Oral Tablet, Coated by Genentech, Inc.
- 64116-121 Esbriet 267 mg Oral Capsule by Intermune, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50242-122Next: 50242-125 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.